Evaluation of Effectiveness and Safety of Levemir (Insulin Detemir), NovoMix (Biphasic Insulin Aspart) and/or NovoRapid (Insulin Aspart) in Insulin naive Subjects With Type 2 Diabetes.

Trial Profile

Evaluation of Effectiveness and Safety of Levemir (Insulin Detemir), NovoMix (Biphasic Insulin Aspart) and/or NovoRapid (Insulin Aspart) in Insulin naive Subjects With Type 2 Diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Dec 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 09 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top